Arkolith/Insider Trading/INBX/Form 4

Kayyem Jon Faiz

DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Dec 17, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2024Gift(G)250K—$0250K
Dec 16, 2024Gift(G)500K—$0509K
Dec 16, 2024Gift(G)250K—$0250K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000068) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML